Oncotarget

Research Papers:

Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma

Wataru Shigeeda, Masahiko Shibazaki _, Shinji Yasuhira, Tomoyuki Masuda, Tatsuo Tanita, Yuka Kaneko, Tatsuhiro Sato, Yoshitaka Sekido and Chihaya Maesawa

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:93729-93740. https://doi.org/10.18632/oncotarget.20750

Metrics: PDF 1077 views  |   HTML 1449 views  |   ?  


Abstract

Wataru Shigeeda1,3, Masahiko Shibazaki1, Shinji Yasuhira1, Tomoyuki Masuda2, Tatsuo Tanita3, Yuka Kaneko1, Tatsuhiro Sato4, Yoshitaka Sekido4 and Chihaya Maesawa1

1Department of Tumor Biology, Institute of Biomedical Science, Iwate Medical University, Iwate, Japan

2Department of Pathology, School of Medicine, Iwate Medical University, Iwate, Japan

3Department of Thoracic Surgery, School of Medicine, Iwate Medical University, Iwate, Japan

4Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan

Correspondence to:

Masahiko Shibazaki, email: mashiba@iwate-med.ac.jp

Keywords: invasion, migration, mesothelioma, RHAMM, YAP1/TAZ

Received: April 07, 2017     Accepted: July 29, 2017     Published: September 08, 2017

ABSTRACT

Most malignant mesotheliomas (MPMs) frequently show activated forms of Yes-associated protein 1 (YAP1) and transcriptional co-activator with PDZ-binding motif (TAZ), which transcriptionally regulates the receptor for hyaluronic acid-mediated motility (RHAMM). As RHAMM is involved in cell migration and invasion in various tumors, we speculated that hyaluronic acid (HA) in pleural fluid might affect the progression of mesothelioma by stimulating cell migration and invasion through RHAMM. The level of RHAMM expression was decreased by YAP1/TAZ knockdown, and conversely increased by forced expression of the active form of YAP1, suggesting that RHAMM was regulated by YAP1/TAZ in MPM cells. Cell migration and invasion were also decreased by YAP1/TAZ or RHAMM knockdown. Notably, HA treatment increased cell motility and invasion, and this was abolished by RHAMM knockdown, suggesting that HA may augment local progression of MPM cells via RHAMM. Furthermore, treatment with fluvastatin, which regulates RHAMM transcription by modulating YAP1/TAZ activity, decreased the motility and invasion of MPM cells. Collectively, these data suggest that HA is an “unfavorable” factor because it promotes malignancy in mesothelioma and that the YAP1/TAZ-RHAMM axis may have potential value as a therapeutic target for inhibition of disease progression in MPM.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 20750